Deepverge PLC Exercise of Warrants and Total Voting Rights (8049M)

TIDMDVRG

RNS Number : 8049M

Deepverge PLC

25 January 2021

AIM share code: DVRG

25 January 2021

DeepVerge PLC

("DeepVerge" or "Company")

Exercise of Warrants

DeepVerge announces that it has received notification from a warrant holder to exercise warrants over 535,714 shares in the share capital of DeepVerge ("the Warrant Shares") at an exercise price of 20 pence. T he consideration for the exercise of the Warrant Shares amounts, in aggregate, to a cash value of GBP107,143.

The Warrant Shares were allotted on 25 January 2021. Application has been made for the Warrant Shares to be admitted to trading on AIM ("Admission"), and Admission is expected to be on or about 29 January 2021. These shares will rank pari passu with the ordinary shares of the Company in issue.

Total voting rights

The Company's total issued capital, after the issue of the Warrant Shares, will be 170,075,785 ordinary shares. As the Company does not hold any shares in Treasury, this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company following Admission.

Contacts

 
                                                   [phone] 
 DeepVerge plc              Gerard Brandon, CEO     648 
 
 SPARK Advisory Partners 
  Limited                   Neil Baldwin/Andrew    [phone] 
  (Nominated Adviser)        Emmott                 8974 
 
 Turner Pope Investments    Andy Thacker/Zoe       [phone] 
  (TPI) Limited (Broker)     Alexander              0050 
 

About DeepVerge plc (www.deepverge.com)

DeepVerge is an environmental and life science group of companies that develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus and toxins. Utilising artificial intelligent data analytics to scientifically prove the impact of skincare product claims on skin microbiome for most of the top 20 global cosmetic company clients and remotely detect and identify in real-time, dangerous pathogens in wastewater treatment plants, drinking water, rivers, lakes and reservoirs.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

IOEZZGZMDKGGMZM

(END) Dow Jones Newswires

January 25, 2021 09:22 ET (14:22 GMT)